Stocktoria
ADIAL PHARMACEUTICALS, INC. ADIL
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2018-07-27
ADIAL PHARMACEUTICALS, INC. financials (annual)
Bars are annual figures from 2017 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| R&D expense | $2.6M | $3.2M | $1.3M | $2.0M | $8.4M | $5.9M | $4.0M | $368,459 | $182,107 |
| Operating income | -$7.8M | -$8.3M | -$6.9M | -$10.9M | -$19.3M | -$10.9M | -$8.2M | -$7.0M | -$995,286 |
| Income tax | — | — | — | -$502 | -$94,077 | — | — | — | — |
| Net income | -$8.0M | -$13.2M | -$5.1M | -$12.7M | -$19.4M | -$10.9M | -$8.6M | -$11.6M | -$1.1M |
| EPS (diluted) | $-11.93 | $-68.01 | $-3.60 | $-12.71 | $-1.04 | — | — | — | — |
| Operating cash flow | -$6.5M | -$6.9M | -$6.8M | -$11.2M | -$11.9M | -$7.6M | -$6.3M | -$2.5M | -$494,862 |
| Free cash flow | — | — | — | — | -$12.0M | — | — | — | — |
| Cash & equivalents | $5.9M | $3.8M | $2.8M | $4.0M | $6.1M | $4.4M | $6.8M | $3.9M | $18,248 |
| Total assets | $6.7M | $5.0M | $4.7M | $5.7M | $7.5M | $5.5M | $7.7M | $4.7M | $34,546 |
| Total liabilities | $1.4M | $975,858 | $653,076 | $2.5M | $4.0M | $1.5M | — | — | — |
| Shareholders' equity | $5.3M | $4.1M | $4.1M | $3.3M | $3.5M | $4.0M | $7.1M | $4.4M | -$997,553 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.